| 摘要 |
PURPOSE:To provide a new immune function activating agent which can be administered by oral administration, transcutaneous administration and injection, an analgesic, their animal drugs, new LPS acting as the active component of the agent and new bacterial strain capable of producing the LPS. CONSTITUTION:Three kinds of LPS compounds having the following physical properties. (1) LPS1, principal molecular weight, 5,000+ or -1,000 (SDS-PAGE process); number of phosphorus atoms, 2+ or -1/5,000 molecular weight; number of hexosamine groups, 9+ or -1/5,000 molecular weight; number of KDO groups, 2+ or -1/5,000 molecular weight: (2) LPS2, principal molecular weight, 6,500+ or -2,500 (SDS-PAGE process); number of phosphorus atoms, 1-2/5,000 molecular weight; number of hexosamine groups, 7+ or -1/5,000 molecular weight; number of KDO groups, 1-2/5,000 molecular weight: (3) LPS3, principal molecular weight, 6,500+ or -2,500 (SDS-PAGE process); number of phosphorus atoms, 2+ or -1/5,000 molecular weight; number of hexosamine groups, 5+ or -1/5,000 molecular weight; number of KDO groups, 2+ or -1/5,000 molecular weight. |
